RedHill Biopharma to Host Third Quarter 2016 Financial Results Conference Call on November 14, 2016
Nov 07, 2016 13:01 pm UTC| Business
TEL-AVIV, Israel, Nov. 07, 2016 -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on development and commercialization of late...
MyoKardia Reports Progress on Clinical Programs and Third Quarter 2016 Financial Results
Nov 07, 2016 13:01 pm UTC| Business
Dosing in Phase 2 PIONEER-HCM trial of MYK-461 in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Under Way; Pathway to Registration OutlinedMYK-491 Dilated Cardiomyopathy Candidate Set to Enter Clinic in First Half...
MyoKardia Reports Progress on Clinical Programs and Third Quarter 2016 Financial Results
Nov 07, 2016 13:01 pm UTC| Business
Dosing in Phase 2 PIONEER-HCM trial of MYK-461 in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Under Way; Pathway to Registration OutlinedMYK-491 Dilated Cardiomyopathy Candidate Set to Enter Clinic in First Half...
Toll Brothers Announces Entry Into Boise, Idaho Market With Acquisition of Coleman Homes
Nov 07, 2016 13:01 pm UTC| Business
HORSHAM, Pa., Nov. 07, 2016 -- Toll Brothers, Inc., (NYSE:TOL) (www.tollbrothers.com), the nation's leading builder of luxury homes, today announced its entry into the Boise, Idaho market through the acquisition of...
Toll Brothers Announces Entry Into Boise, Idaho Market With Acquisition of Coleman Homes
Nov 07, 2016 13:01 pm UTC| Business
HORSHAM, Pa., Nov. 07, 2016 -- Toll Brothers, Inc., (NYSE:TOL) (www.tollbrothers.com), the nation's leading builder of luxury homes, today announced its entry into the Boise, Idaho market through the acquisition of...
TubeMogul Debuts Attribution Solution
Nov 07, 2016 13:01 pm UTC| Business
EMERYVILLE, Calif., Nov. 07, 2016 -- Today, TubeMogul (NASDAQ:TUBE) announced the launch of Ad Swap to help marketers better isolate causality in advertising measurement. ...
Threshold Pharmaceuticals Reports Third Quarter Financial Results
Nov 07, 2016 13:01 pm UTC| Business
-- Planning to initiate a clinical trial of evofosfamide in combination with checkpoint inhibitors -- SOUTH SAN FRANCISCO, Calif., Nov. 07, 2016 -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD), a clinical-stage...